- Home
- INDI vs KOD Comparison
INDI vs KOD Comparison
Compare INDI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDI | KOD |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | INDI | KOD |
|---|---|---|
| Price | $3.54 | $23.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $6.25 | ★ $22.29 |
| AVG Volume (30 Days) | ★ 4.0M | 774.9K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $217,396,000.00 | N/A |
| Revenue This Year | $4.53 | N/A |
| Revenue Next Year | $31.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.53 | $1.92 |
| 52 Week High | $6.05 | $23.63 |
Technical Indicators
Market Signals| Indicator | INDI | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 67.24 |
| Support Level | $3.15 | $19.25 |
| Resistance Level | $3.68 | $23.63 |
| Average True Range (ATR) | 0.27 | 1.92 |
| MACD | -0.05 | 0.24 |
| Stochastic Oscillator | 22.09 | 89.70 |
Price Performance
Historical ComparisonAbout INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.